Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $40.5850 (-1.08%) ($40.5850 - $40.5850) on Thu. Sep. 14, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.25% (three month average) | RSI | 43 | Latest Price | $40.5850(-1.08%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.7% a day on average for past five trading days. | Weekly Trend | HALO declines -4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) XBI(67%) BWX(61%) IVE(59%) XLF(52%) XRT(50%) | Factors Impacting HALO price | HALO will decline at least -1.125% in a week (0% probabilities). VXX(-42%) TBT(-33%) OIH(-28%) INDA(-66%) LIT(-27%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.125% (StdDev 2.25%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $32.16(-20.76%) | Resistance Level | $41.39 | 5 Day Moving Average | $39.3(3.27%) | 10 Day Moving Average | $40.24(0.86%) | 20 Day Moving Average | $41.39(-1.94%) | To recent high | -7.8% | To recent low | 18.9% | Market Cap | $5.547b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |